A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation

Status:
Completed

Trial end date:
2002-01-01

Target enrollment:

Participant gender:

The purpose of the study is to measure the safety and efficacy of three doses of varenicline for smoking cessation.

Phase 2

Pfizer

Varenicline